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ABSTRACT To investigate the interplay between the thin and thick ﬁlaments during calcium activation in striated muscle, we
employed n-(6-aminohexyl) 5-chloro-1-napthalenesulfonamide (W7) as an inhibitor of troponin C and compared its effects with
that of the myosin-speciﬁc inhibitor, 2,3-butanedione 2-monoxime (BDM). In both skeletal and cardiac ﬁbers, W7 reversibly
inhibited ATPase and tension over the full range of calcium activation between pCa 8.0 and 4.5, resulting in reduced calcium
sensitivity and cooperativity of ATPase and tension activations. At maximal activation in skeletal ﬁbers, the W7 concentrations
for half-maximal inhibition (KI) were 70–80 mM for ATPase and 20–30 mM for tension, nearly >200-fold lower than BDM (20 mM
and 5–8 mM, respectively). When W7 (50 mM) and BDM (20 mM) were combined in skeletal ﬁbers, the ATPase and tension-
pCa curves exhibited lower apparent cooperativity and maxima and higher calcium sensitivity than expected from two
independent activation pathways, suggesting that the interplay between the thin and thick ﬁlaments varies with the level of
activation. Signiﬁcantly, the inhibition of W7 increased the ATPase/tension ratio during activation in both muscle types. W7
holds much promise as a potent and reversible inhibitor of thin ﬁlament-mediated calcium activation of skeletal and cardiac
muscle contraction.
INTRODUCTION
Calcium activation of contraction and its regulation in
vertebrate striated muscle involve both the thin and the thick
ﬁlaments. Initiation of activation is triggered by the binding
of calcium to troponin C (TnC), followed by conformational
changes and movement of the troponin/tropomyosin com-
plexes of the thin ﬁlament that render the force-generating
interactions between actins of the thin ﬁlaments and myosin
motors of the thick ﬁlaments. The interaction between the
two ﬁlament systems is thought to be interdependent, with
each system simultaneously responding to and inﬂuencing
the other system (Gordon et al., 2000). The interplay of the
two ﬁlaments has been examined experimentally by two
general approaches: 1), preferential extraction and reconsti-
tution or exchange with modiﬁed or analogous proteins; and
2), the use of speciﬁc inhibitors (usually small chemical
compounds) to perturb or inhibit protein interactions. In the
present study, we have employed inhibitors that preferen-
tially target either the TnC in the thin ﬁlament or the myosin
heads in the thick ﬁlament, to gain further understanding of
the relative contribution and interdependence of the activa-
tion processes of the thin and the thick ﬁlaments.
To inhibit the thin ﬁlament activation via TnC, we
utilized n-(6-aminohexyl) 5-chloro-1-napthalenesulfona-
mide (W7) as an inhibitor, a compound originally developed
as a potent and speciﬁc inhibitor of calmodulin (CaM)
function (Hidaka et al., 1980). W7 is known to bind
speciﬁcally and with high afﬁnity to CaM (Kd ¼ 11 mM at
258C) and to TnC (Kd ¼ 25 mM at 258C), but not to actin,
myosin, or tropomyosin (Tm) (Hidaka et al., 1980). W7
binds to the hydrophobic pocket formed by the EF hands
within each domain of CaM and competes directly with the
binding of CaM-dependent enzymes (Osawa et al., 1998).
Although W7 binds to TnC in solution, its potential ability
to inhibit muscle activation was curiously not borne out by
previous work in skinned rabbit psoas ﬁbers (Ogawa and
Kurebayashi, 1989). We found that, contrary to this early
work, W7 indeed is a potent and reversible inhibitor of
calcium activation in skinned ﬁbers from both rabbit skeletal
and mouse cardiac muscles.
The inhibitory effect of W7 in skeletal ﬁbers was com-
pared with that of 2,3-butanedione 2-monoxime (BDM),
a widely used inhibitor that targets actively cycling myosin
heads (Herrmann et al., 1992; McKillop et al., 1994) and
inhibits ATPase uncompetitively by stabilizing the posthy-
drolysis state before the force-generating isomerization state
(McKillop et al., 1994; Regnier et al., 1995; Tesi et al., 2002;
Zhao et al., 1995; Zhao and Kawai, 1994). The combined use
of W7 and BDM offers an opportunity to examine the degree
and the mechanism of coupling between the thin and the
thick ﬁlaments during calcium activation of contraction. To
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assess the inhibition in rabbit skeletal and mouse cardiac
muscle, we measured the activations of ATPase and tension
simultaneously as calcium concentration was increased con-
tinuously from pCa 8.0 to 4.5. Comparison of the extent of
inhibition and the coupling between ATPase and tension
were facilitated by subjecting the same samples to several
cycles of activation/relaxation in the presence of the
inhibitors. The ATPase- and tension-pCa curves were ﬁtted
with the Hill equation to determine the cooperativity and
calcium sensitivity of activation (Donaldson and Kerrick,
1975).
We report that W7 is a potent and reversible inhibitor of
thin ﬁlament-mediated calcium activation in skeletal and
cardiac ﬁbers. W7 reversibly reduces the ATPase, tension
and the tension cost (ATPase/tension ratio) over the entire
range of activation by calcium. The comparison of W7 and
BDM inhibitions in skeletal and cardiac ﬁbers revealed the
interdependence of thin- and thick-ﬁlament-based activa-
tions in each muscle type.
EXPERIMENTAL PROCEDURES
Sample preparation
Bundles of skinned rabbit psoas ﬁbers were prepared from
adult white New Zealand rabbits (;2 kg) as described
previously (Adhikari and Wang, 2001). Skinned ﬁber
bundles from mouse papillary were prepared according to
Fewell et al. (1998). After euthanasia of mice by CO2 and
cervical dislocation, the heart was removed and immediately
immersed in solution A (5.37 mM Na2ATP, 30 mM
phosphocreatine, 5 mM K-EGTA, 20 mM BES, 7.33 mM
MgCl2, 0.12 mM CaCl2, 10 mM DTE, 1% (v/v) protease
inhibitor cocktail (P-8340, Sigma, St. Louis, MO), 30 mM
BDM, and 32 mM potassium methanesulfonate, pH 7.0).
Uniform sections of left ventricular papillary tissues (;0.5
mm 3 2–3 mm) were dissected and skinned in solution B
(5.5 mM Na2ATP, 5 mM K-EGTA, 20 mM BES, 6.13 mM
MgCl2, 0.11 mM CaCl2, 10 mM DTE, the protease inhibitor
cocktail, 121.8 mM potassium methanesulfonate at pH 7.0,
and 50% glycerol and 0.5% (v/v) Triton X-100) for 12 h, and
stored in solution B without detergent at –208C until use.
Single rabbit psoas ﬁbers were dissected from bundles
under relaxing solution (Table 1) and glued to aluminum
T-clips (;0.5 3 2 mm) using an octyl-formulated cyano-
acrylate glue (Nexaband S/C, Closure Medical Corporation,
Raleigh, NC) at a length of ;1.5–2 mm and attached via
holes in the T-clips. The attachment was via tweezers
without the T-clips for the simultaneous pCa-ATPase and
pCa-tension measurements (Fig. 1 A). Mice papillary tissues
were dissected under solution A to get thin and uniform ﬁber
bundles (;100–150 mm 3 2 mm) and subjected to a further
skinning for 4–6 h in solution B. All calcium activation
experiments were carried out at 208C at a preset sarcomere
length (SL) ¼ 2.2 mm.
Solution compositions
Solution compositions for the ﬁber experiments are given in
Table 1. Isometric tension and stiffness experiments at pCa
4.0 were carried out with relaxing and activating solutions
with ATP-regenerating backup system. Calcium activation
experiments were carried out in Rx-NADH and Act-NADH
solutions. The concentrations of free Ca21, free Mg21,
MgATP, and the total ionic strength in these solutions were
calculated using the program MaxChelator V1.75 (Chris
Patton, Stanford University; http://www.stanford.edu/cpat-
ton/maxc.html, August, 1998). The dissociation constants of
metal ion chelators in the solution were taken from Martell
and Smith (1974). Calculated solution pCa was routinely
veriﬁed with calcium selective electrode (Orion Research,
Beverly, MA) using calibrated pCa standards (WPI, Sara-
sota, FL).
Tension and dynamic stiffness measurements
A previously described instrument (Granzier and Wang,
1993) with modiﬁcations was used to measure tension and
dynamic stiffness (single or sweeps between 1 and 2000 Hz)
under isometric conditions. Stiffness refers to the dynamic
stiffness determined by the ratio of the amplitudes of tension
and percent ﬁber length resulting from sinusoidal oscillations
(0.1% ﬁber length or ;1 nm per half sarcomere s1)
imposed at one end of ﬁber through the length transducer.
Fiber cross-sectional area was calculated assuming uniform
cylindrical diameter from the average of 4–8 measurements
taken at equidistant points along ﬁber axis at a magniﬁcation
of 4003.
TABLE 1 Solutions used for mechanical studies
Rigor Relaxing Rx-NADH Activating Act-NADH
Imidazole (mM) 10 10 10 10 10
K2-EGTA (mM) 12 12 12 0 0
K2Ca-EGTA
(mM)
0 0 0 12 12
Magnesium
acetate (mM)
1.3 3.0 3.0 2.5 2.5
KPr (mM) 138 117 127 116 128
Na2ATP (mM) 0 1.8 1.8 1.8 1.8
DTT (mM) 1 1 1 1 1
CP (mM) 0 5 0 5 0
CPK (units/ml) 0 200 0 200 0
NADH (mM) 0 0 0.4 0 0.4
LDH (units/ml) 0 0 140 0 140
PK (units/ml) 0 0 100 0 100
PEP (mM) 0 0 5 0 5
Leupeptin
(mg/ml)
20 20 20 20 20
pH 7.0 7.0 7.0 7.0 7.0
Ionic strength
(mM)
180 180 180 180 180
pCa ;8.0 ;8.0 ;8.0 4.0 4.0
[MgATP] (mM) 0 1.5 1.5 1.5 1.5
[Mg21] (mM) 1 1 1 1 1
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pCa curves of tension and ATPase
The pCa curves of ATPase and tension for a given ﬁber from
pCa 8.0 to 4.6 at 208C (Fig. 1 A) were determined sim-
ultaneously in a commercially available instrument (Sci-
entiﬁc Instrument, Heidelberg, Germany), as described
previously (Adhikari and Wang, 2001). Typically, multiple
cycles of activation, each preceded by a relaxation period,
were carried out on the same sample at different inhibitor
concentrations to determine the extent and reversibility of the
inhibition. Raw data from one of the activation cycles (Fig.
4, II-Cycle 2) after treatment and washing of W7 are shown
in Fig. 1 B. Each spike in the tension and ATPase traces
corresponds to the successive perfusions of the sample. The
ATPase, given by the rate of decrease of NADH ﬂuorescence
between each perfusion, and the tension remain at baseline
values until sufﬁcient calcium is available to activate the
ﬁber and trigger a rapid response to saturating values at
higher calcium (lower pCa). ATP turnover per myosin head
s1 were determined by calibration of ﬂuorescence intensity
with known concentrations of NADH, assuming myosin
head concentration of 150 mM (Bagshaw, 1993).
The pCa curves of ATPase and tension, normalized to the
maximum values in the absence of inhibitors either before or
after treatment, were ﬁtted using nonlinear routines (Math-
CAD 8.0, MathSoft, Cambridge, MA) with the following
equation,
Y ¼ Ymax½Ca21n=ðaCKnM1aU½Ca21nÞ; (1)
which can be written as
y ¼ ymax=ðaU1aC10nðpCaKMÞÞ; (2)
where ymax and KM denote, respectively, the maximum
activation (100%) and the pCa at which activation is at the
half-maximum (pK) for the pCa curves without the inhi-
bitors. For all pCa curves, n is the slope and represents a mea-
sure of the cooperativity of activation. In the presence of an
inhibitor, the coefﬁcients, aC, aU ($1), determine the de-
creases in the pK (as a measure of competitive inhibition)
and the maximal activation (as a measure of uncompetitive
inhibition), respectively. The pK is given by (KM-log (aC)/n)
and the relative maximal activation is given by 100%/aU. In
the absence of inhibitor, aC, aU ¼ 1, and Eq. 2 then reduces
to the Hill equation used previously for the analysis of pCa
curves (Donaldson and Kerrick, 1975).
RESULTS
Inhibition of tension and stiffness in skeletal
ﬁbers by W7 at pCa 4.0
When increasing concentrations of W7 (0–300 mM) were
added to a skinned single rabbit psoas ﬁber undergoing
isometric contraction at pCa 4.0 at 208C, tension declined
incrementally with the added W7, reaching 4% of maximal
values without W7 at 300 mM (Fig. 2 A). Subsequent
washing to remove free W7 restored the tension to the same
level as untreated control ﬁbers (Fig. 2 A), with a slow
decline of maximal isometric tension over the time course of
the experiments. The inhibition was stable for at least 16 min
(not shown), repeatable (e.g., Fig. 2, B and C), and
independent of the sequence of the treatments (Fig. 2, A
and B). Prior activation was not necessary for this effect,
since activation in the presence of W7 produced the same
degree of inhibition as that of W7 treatment after activation
(Fig. 2, B and C).
The inhibition of tension (at 208C and 58C) and dynamic
stiffness (208C) as a function of W7 concentration is shown
in Fig. 3. The decline in tension at both temperatures was
rapid initially, dropping to 30% between 0 and 50 mM, but
became much more moderate at higher concentrations. W7
inhibited tension more effectively at 208C than 58C. Its
inhibition of dynamic stiffness (at 96 Hz, 440 Hz, and 2 kHz)
followed closely and appeared proportionally with that of
tension (inset, Fig. 3). Simple hyperbolic curves ﬁt the
tension data reasonably well, yielding concentrations for
half-maximal inhibition (KI-Tension) of 22 and 32 mM,
FIGURE 1 Schematic of instrument and an example of raw data obtained
during calcium activation of ATPase and tension. (A) Single skeletal ﬁber or
a small bundle of cardiac papillary ﬁbers is mounted between two tweezers,
one attached to a length controller and the other to a force transducer, inside
a cuvette. Solution of varying pCa can be pumped around the sample using
a peristaltic pump and a pCa gradient maker that mixes solutions of low and
high calcium. For ﬂuorescence measurements, excitation light is focused on
the sample, and two detectors, one of each for the signal and the background,
are used to collect the resulting ﬂuorescence with appropriate excitation and
emission ﬁlters. Sarcomere length is measured from diffraction patterns from
a He-Ne laser. (B) Raw data of NADH ﬂuorescence (ATPase) and tension
that are used to construct two calcium activation curves of the same single
rabbit psoas ﬁber.
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respectively, at 20 and 58C (Fig. 2). The KI-Tension at 208C
observed here is close to the reported dissociation constant of
25 mM between W7 and TnC measured in solution at 258C
(Hidaka et al., 1980).
Inhibition of calcium activation of ATPase and
tension in skeletal ﬁbers by W7
W7 greatly reduced the magnitudes and calcium sensitivities
of ATPase and tension over the entire pCa range between 7.0
and 4.8. At 300 mM, W7 abolished tension nearly
completely; however, residual ATPase (;17%) between
pCa 5.8 and 5.0 remained (Fig. 4, I-Cycle 1). When the
concentration was reduced in successive activation cycles,
ATPase and tension recovered correspondingly, with the
curves at 0 mM returning to the steep and high amplitude
curves typical of the untreated ﬁbers (Fig. 4, untreated ). The
maximum activations of ATPase and tension were, re-
spectively, 39 and 11% at 100 mM and 83 and 58% at 20
mM. It is interesting that ATPase is more sensitive to calcium
activation, with a pK that is higher by ;10.12 than that of
the tension pCa curves without W7 (Fig. 4, untreated ). This
difference was widened to 10.2 to 0.4 at higher concen-
trations of W7 (Fig. 4). From the variations of maximal
ATPase and maximal tension against W7, KI-ATPase, and KI-
Tension were determined as ;75 mM and ;25 mM,
respectively.
A closer examination of the deviations of experimental
and ﬁtted ATPase-pCa curves revealed the likely presence of
three component curves (Fig. 4). The ﬁrst component (l ) was
observed at the onset of activation between pCa 6.6 and 5.9
(bracket, Fig. 4, I-Cycle 2). This leading component (l ),
which peaks at ;20% of the maximal ATPase value, was
frequently, but not always, inhibited by W7. The second and
major component comprised ;80% of the total maximal
ATPase observed between pCa 5.9 and 5.0 and was W7-
sensitive (ﬁtted solid curve, Fig. 4, I-Cycle 2). A third,
trailing component (t) was observed between pCa 5.6 and 5.0
that accounted for ;17% of the maximal ATPase and was
uninhibited by high concentrations of W7 to at least 300 mM
(bracket, Fig. 4, II-Cycle 1).
Inhibition of cardiac muscle activation by W7
Since TnC-mediated calcium activation is analogous in
skeletal and cardiac muscle, we evaluated whether W7 has
a similar effect on mouse papillary muscle. As in skeletal
ﬁbers, the inhibition of activations of ATPase and tension by
W7 was reversible and characterized by reduced maxima and
reduced calcium sensitivities. However, cardiac ﬁbers ap-
peared to be more resistant to W7, with a KI-ATPase of ;80
mM and KI-Tension of ;25 mM.
The maximal ATPase and tension in the same papillary
ﬁber bundle were 48 and 25% at 100 mM (Fig. 5, Cycle 2);
58 and 40% at 25 mM (Fig. 5, Cycle 3); and ﬁnally, after
washing, restored to 80 and 70% at 0 mM (Fig. 5, Cycle 4).
In the absence of W7 (Fig. 5, Cycle 1), the ATPase and
tension-pCa curves nearly coincided, with a pK at 5.4 (cf.
Allen et al., 2000; Wang et al., 1999). Closer examination of
this and other curves indicated that ATPase curves
frequently led the tension curves by a small but detectable
FIGURE 3 Isometric tension and stiffness at pCa 4.0 of rabbit psoas ﬁbers
as a function of W7 concentration. Tension was normalized to values
obtained without W7. The data were obtained from four experiments at 208C
(solid symbols) and three experiments at 58C (unﬁlled symbols). The solid
lines are drawn to ﬁt the tension data using an equation of a hyperbola with
half-maximal values (KI-Tension) of 22 mM at 208C and 32 mM at 58C. Inset
shows the proportionality between tension and stiffness (2000, 440, and 96
Hz) at the indicated W7 concentrations at 208C.
FIGURE 2 The reversible inhibition of isometric tension of rabbit psoas
ﬁbers by W7 at pCa 4.0. (A) A single ﬁber, initially under relaxation, was
activated at pCa 4.0 and subjected to increasing and decreasing concen-
trations of W7 before another ﬁnal relaxation. The numbers above the trace
indicate the concentration of W7 in mM. (B) Another ﬁber was treated with
300 mM W7 after activation, which resulted in tension levels approaching
the relaxing value, and then treated with 50, 20, and 10 mM W7 with
a corresponding recovery of tension. Subsequently, when the ﬁber was
treated with relaxing solution the tension returned to relaxing values. (C)
The same ﬁber from B after 10 min relaxation was activated ﬁrst in 300 mM
W7; then without W7; then ﬁnally relaxed.
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difference of 0.03 pCa unit (Fig. 5, Cycle 1). This lead was
signiﬁcantly widened in W7 treated ﬁbers, to 10.16 at 100
mM (Fig. 5, Cycles 2–4). Subsequent washing of treated
ﬁbers did little to narrow the lead, despite the restoration
of ATPase and tension. Interestingly, the leading ATPase
component of skeletal ﬁbers, activated between pCa 6.6 and
5.8, was absent in cardiac ﬁbers (Fig. 5).
Alteration of calcium activation in skeletal ﬁbers
by W7 and BDM
We next compared the W7 inhibition with BDM in rabbit
psoas ﬁbers to explore whether the combined use of W7 and
BDM could provide insights on the interplay of the thin
ﬁlament- and thick ﬁlament-based pathways of calcium
activation. Fig. 6 shows the results of calcium activation of
FIGURE 4 The reversible inhibition of calcium activa-
tion of ATPase and tension of single rabbit psoas ﬁbers by
W. The pCa curves of ATPase (unﬁlled symbols) and
tension (solid symbols) from two adjacent sections (I and
II ) of a single ﬁber are plotted against the solution pCa.
Multiple activation cycles, each preceded by a period of
relaxation, were carried on two adjacent sections of a single
ﬁber in the presence of the indicated concentrations of W7.
The activation sequences were 100 mM (I-Cycle 1) and
0 mM (I-Cycle 2) in the ﬁrst ﬁber section, and 300 mM (II-
Cycle 1), 20 mM (II-Cycle 2), and 0 mM (II-Cycle 3) in the
second ﬁber section. The data were normalized to the
curves at 0 mM W7 in each set. The ﬁtted values of
midpoint (pK) and slope (n, in parentheses) are given next
to each curve. An example of ATPase/force-pCa curves
from an untreated ﬁber is shown for comparison. The
brackets (l for leading component and t for trailing
component) indicate the components of ATPase that are
not accompanied by signiﬁcant levels of tension.
FIGURE 5 The reversible inhibition of calcium activa-
tion of ATPase and tension by W7 in mouse heart ﬁbers.
All activation curves were obtained sequentially from the
same sample, after relaxation of muscle between each
activation, in the following order: without W7 (Cycle 1),
with 100 mM W7 (Cycle 2), with 25 mM W7 (Cycle 3),
and ﬁnally again after washing W7 (Cycle 4). The data
were normalized to the curves obtained in the ﬁrst
activation cycle without W7 (Cycle 1). The ﬁtted values
of pK and n (in parentheses) are given next to each curve.
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a ﬁber treated sequentially with BDM and/or W7 in four
cycles. The maximal ATPase and tension were diminished to
40 and 12%, respectively, in 30 mM BDM, with the tension
inhibition comparable to previous studies (Martyn et al.,
1999). Based on such curves, KI-ATPase and KI-Tension of
BDM were 20 mM and 5–8 mM, respectively (data not
shown). In 10 mM BDM and 50 mMW7, tension maximum
was reduced to nearly zero (1.7%) whereas the ATPase
maximum was 22%. These values were comparable to the
inhibition observed in 300 mM W7 (Fig. 4) but signiﬁcantly
lower than those in 30 mM BDM. Upon reactivation of the
same ﬁber in 10 mM BDM, the maximal ATPase and ten-
sion returned to 60 and 35%, respectively. When the ﬁber
was washed to remove free W7 and BDM, the activations
approached untreated levels. Interestingly, the leading com-
ponent of ATPase activation between pCa 6.6 and 5.9
(bracketed in Fig. 4, I-Cycle 2; Fig. 6, Cycle 4), which was
inhibited by W7 (Fig. 4, I-Cycle 1, and II-Cycles 1 and 2),
was also reduced by BDM (Fig. 6, Cycles 1 and 3).
It is signiﬁcant that the maximal ATPase and tension and
their apparent cooperativity to calcium were much lower in
W7 plus BDM than in W7 or BDM alone (Fig. 7 A). To
analyze this difference over the entire range of activation, we
calculated theoretical curves on the assumption that two
inhibitors act independently, so that the total inhibition is
the arithmetic sum of individual curves (normalized to the
maximal values of untreated ﬁbers) for each inhibitor. As
shown in Fig. 7 B, the predicted pCa curves of W7 plus
BDM intersected with the experimental curves of W7 plus
BDM near pCa ;5.3 for both ATPase (unﬁlled symbols in
Fig. 7 B) and tension curves (solid symbols in Fig. 7 B). Thus
at pCa >5.3, the two inhibitors appear to interfere with each
other to give a higher ATPase and tension than those
predicted; at pCa\5.3, the two inhibitors appear to enhance
the inhibition, resulting in lower ATPase and tension than
those predicted.
The inhibitory effects of W7 and BDM in skeletal ﬁbers
were largely reversible. Untreated ﬁbers developed on
average 182 6 5 kN/m2 tension with ATP turnover rate of
3.5 6 0.2 s1 per active myosin site at maximal activation
(Table 2). This ATP turnover rate is comparable to recently
published values (Hilber et al., 2001). After the washing to
remove inhibitors, the ﬁbers displayed a slightly lower
maximal ATPase (by 14%) and maximal tension (by 5%). In
normalized pCa curves, the pK of ATPase and tension
decreased by 0.1 and 0.18 pCa units, respectively, with
a corresponding drop of n-values by ;2 and ;3 (Table 2).
These changes are comparable to those of ﬁbers that were
taken through two consecutive activation cycles in the ab-
sence of inhibitors (data not shown).
Tension cost curves during skeletal and cardiac
muscle activation
Tension cost, deﬁned as the ratio of ATPase to tension, both
normalized to maximal activation values in the absence of
inhibitors, is a useful measure of the efﬁciency of conversion
of chemical energy into mechanical energy of the muscle
ﬁber (e.g., Kushmerick and Krasner, 1982). On the assump-
tion that ATPase is myosin-based under our experimental
conditions, the tension cost for untreated skeletal ﬁbers
upon activation declined steeply from ;6 at pCa of 5.6/5.7
to a plateau value of 1 below pCa 5.5 (Fig. 8 A). The tension
cost from pCa 6.6 to 5.7 is undeﬁned, since no force was
measurable for this leading component of the ATPase-pCa
curves (see above). This tension cost-pCa curve indicates that
the coupling between ATPase and force generation at the
onset of activation is suboptimal and becomes increasingly
FIGURE 6 The inhibition of calcium activation of
tension and ATPase of a rabbit psoas ﬁber by BDM and
by BDM and W7. All activation curves were obtained
sequentially in the same ﬁber, after relaxation of sample
between each activation, in the following order: 30 mM
BDM (Cycle 1), 10 mM BDM plus 50 mM W7 (Cycle 2),
10 mM BDM (Cycle 3), and ﬁnally without BDM and W7
(Cycle 4; note that the ﬁber broke near the maximum
activation). The data were normalized to the curves
without BDM and W7 (Cycle 4; l over bracket indicates
the leading component of ATPase as in Fig. 4). Fitted
values of pK and n (in brackets) are given next to each
curve.
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efﬁcient and reaches a maximum only after this skeletal mus-
cle is fully activated near pCa 5.5 and beyond. Signiﬁcantly,
the tension cost-pCa curve in untreated cardiac ﬁbers was
nearly ﬂat over the entire pCa range (Fig. 8 B). This curve
indicates a constant coupling efﬁciency between ATPase and
tension during activation of cardiac muscles and suggests
a qualitative difference of calcium activation between the
two muscles.
In the presence of W7 for both muscles, the tension cost
increased over the entire pCa range (Fig. 8, A and B). The
tension cost of skeletal ﬁbers in 20 mM W7 was higher
than that of the untreated ﬁber between pCa 5.6 and 4.9.
This curve descended gradually from pCa 5.6 toward pCa
4.9 and plateaued to ;2 at pCa 4.9 (Fig. 8 A). Similarly,
the curve at 100 mM W7 was even higher than 20 mM W7
and plateaued to ;3 (Fig. 8 A). In cardiac ﬁbers treated
FIGURE 7 Enhancement of inhibition
by the combination of 50 mM W7 and 10
mMBDM in single ﬁbers from rabbit psoas
muscle. Average ATPase and tension-pCa
curves are plotted for 50 mM W7, 10 mM
BDM, 50 mM W7, and 10 mM BDM in A.
The pCa curves of the combined W7 and
BDM data are compared with that of the
predicted curves based on sums of each
inhibition curves in B. The ﬁtted values of
pK and n (in parentheses) for the ATPase
and tension curves are given next to each
curve. Note the signiﬁcant drops in coop-
erativity and maximal values that lead to
higher sensitivities when W7 and BDM are
combined. The data were obtained from
individual activations in 3–4 ﬁbers for each
condition.
TABLE 2 The reversibility of W7 and BDM treatment on calcium activation of ATPase and tension in single skeletal ﬁbers
Untreated ﬁbers Posttreated ﬁbers
Maximum* pK Hill (n) Maximum* pK Hill (n)
ATPase 3.5 6 0.2 5.83 6 0.01 6.4 6 0.6 3.0 6 0.2 5.73 6 0.02 4.1 6 0.3
Tension 182 6 5 5.75 6 0.01 9.3 6 0.4 172 6 8 5.57 6 0.02 6.2 6 0.4
*Fibers were activated without treatment (untreated ﬁbers), or treated with both inhibitors, activated, washed, and then reactivated (posttreated ﬁbers).
ATPase is given as ATP turnover per active site per second and tension is in kN/m2. Data are averages of individual analyses of ﬁve activations in ﬁve ﬁbers
in each set.
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with W7, a similar increase in tension cost was observed
with increasing concentrations of W7 (Fig. 8 B). After
washing of treated ﬁbers to remove inhibitors, the tension
cost curves recovered completely for the skeletal muscle
and signiﬁcantly for the cardiac muscle (compare untreated
and posttreated curves in Fig. 8). The skeletal muscle
curve at 30 mM BDM descended from 6 at pCa 5.4 to
a plateau at 3 at pCa 5.1 (Fig. 8 C). These data indicate
that these inhibitors increase the tension cost of contraction
over the entire range of pCa for both skeletal and cardiac
muscles.
DISCUSSION
W7 as a novel inhibitor of skeletal and cardiac
muscle contraction
We have established for the ﬁrst time that a widely used CaM
antagonist, W7, is a potent and reversible inhibitor of
FIGURE 8 Relative tension cost (ATPase/tension)
during activation in the presence of W7 and BDM. The
ATPase/tension ratios are plotted against the solution
pCa for activations of skeletal and cardiac ﬁbers at the
indicated concentrations of W7 and BDM. (A) W7
inhibition in skeletal ﬁbers; (B) W7 inhibition in
cardiac ﬁbers; and (C) BDM inhibition in skeletal
ﬁbers.
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contraction in skeletal and heart muscle ﬁbers. This small,
membrane-permeable inhibitor of high potency and rever-
sibility, is expected to be particularly useful, either by itself
or in combination with other known inhibitors, such as BDM
or the recently reported myosin inhibitor BTS (Cheung et al.,
2002), for the ﬁne control of contraction of live muscle ﬁbers.
It may also be utilized in keeping these muscles relaxed
in the presence of Ca21.
TnC as a primary target for the W7 inhibition of
calcium activation
The W7 inhibition is most likely mediated via speciﬁc
interactions between W7 and TnC. In solution W7 binds
speciﬁcally to TnC and not to Tm, actin, or myosin (Hidaka
et al., 1980). Signiﬁcantly, the KI-Tension values determined
here in both muscle types are in excellent agreement with the
previously determined KD of 25 mM of W7 for TnC in
solution (Hidaka et al., 1980), strongly supporting the notion
that TnC is the primary target for the W7 inhibition.
Recent NMR studies show one molecule of W7 bound to
one domain of CaM, competing directly for the deep
hydrophobic pocket where the CaM-activated regulatory
proteins bind (Osawa et al., 1998). Since the 10 N-terminal
residues of CaM involved in the W7 binding differ from TnC
by only one conservative substitution in fast skeletal TnC
(Ile-60 in place of Met-52 of CaM (Huang et al., 1998;
Osawa et al., 1998) and mouse cardiac TnC (Val-73 in place
of Ile-64) (our unpublished data), it is likely that W7 binds to
TnC in the same way. Additionally, since the overall
conformation and the recognition mechanisms are similar
between the structures of TnC/TnI1-47 (Vassylyev et al.,
1998) and CaM-target peptides (Ikura et al., 1992; Meador
et al., 1992), we speculate that W7 might competitively
inhibit the interactions between TnI and TnC during calcium
activation, thereby disabling the thin ﬁlaments (see Scheme 1
below).
The possibility that inhibition results from TnC extraction
is unlikely, in view of the rapid and reversible action of W7.
Furthermore, our tension-pCa data at varying W7 concen-
trations in skeletal muscle ﬁbers are in excellent general
agreement with recent studies where native TnC was
replaced with varying amounts of nonfunctional TnC
(Regnier et al., 2002), suggesting an inactive TnC upon
W7 binding. Other secondary targets of W7, such as myosin
light chains and other EF hand proteins are conceivable, but
unlikely to be quantitatively signiﬁcant. Solution ATPase
activities of myosin and actomyosin are not signiﬁcantly
altered when light chains (RLC or ELC) are chemically
modiﬁed by spin labels attached to their cysteine residues
(Adhikari et al., 1997; Palm et al., 1999). Even an ;50%
removal of RLC only reduced maximal tension by 20% in
rabbit psoas ﬁbers, (Roopnarine, 2003). Our own studies
showed a slight inhibitory effect of W7 on the in vitro
motility of actin over myosin-heavymeromyosin (e.g., a 25%
reduction at 100 mM W7), whereas the high salt Ca21 and
Mg21 S1 ATPase activities were unaffected up to 300 mM
W7 (B. Adhikari, W. Li, and K. Wang, unpublished obser-
vations). These biochemical data suggest a possible inhibi-
tion of actomyosin interaction, albeit at high concentrations
of W7. Another potential candidate, S100A1, a calcium
sensor protein that modulates skeletal and cardiac muscle
activation (Adhikari and Wang, 2001; Most et al., 2001), is
absent in the skinned muscle ﬁbers used (B. Adhikari and K.
Wang, unpublished observations). S100A1 therefore is not
a relevant target of W7 in these skinned ﬁbers.
Calcium activation: an interplay of the thin and
the thick ﬁlaments
Based on the analysis above, a scheme of the inhibitory
action of W7 in the context of an actomyosin chemo-
mechanical cycle (from Tesi et al., 2002) is presented in
Scheme 1 (A, actin-thin ﬁlament; M, myosin; all inactivated
forms are in italic). During activation of untreated ﬁbers,
Ca21 binds and activates TnC, which in turn activates the
thin ﬁlaments, enabling myosin to interact with actin, to
hydrolyze ATP and to generate force (noforce-to-force
transition). W7 is proposed to bind primarily to the Ca21
bound form of TnC and inactivates the thin ﬁlament (AW7 in
Scheme 1) without altering the binding afﬁnity between
calcium and TnC (Hidaka et al., 1980; Inagaki et al., 1983).
BDM is depicted as inhibiting primarily the A-M.ADP.Pi
state, although other states may be secondary targets (Tesi
et al., 2002, and references cited therein).
Although a quantitative analysis of this molecular scheme
is beyond the scope of this work, some interesting inferences
can be reached. First, since W7 appears to inhibit overall
ATPase and tension both competitively and noncompeti-
tively (as revealed by its reduction of both pK and maximal
activation), we suggest that calcium binding to TnC and the
level of activation of the thin ﬁlaments are inﬂuenced by the
subsequent steps in the cycle. A purely noncompetitive
inhibitor, where both calcium binding to TnC and the level of
thin ﬁlament activation are independent of subsequent steps
(see Eq. 2 in Methods), would reduce ATPase and tension
without reducing pK or n. Likewise, the mixed-type in-
hibition for BDM or for BDM plus W7 is consistent with the
presence of signiﬁcant interdependence between the level of
activation of the thin ﬁlaments and the strength of the actin-
myosin interactions.
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Current molecular models for activation invoke three
states of thin ﬁlaments, corresponding to three positions of
Tm on the thin ﬁlament (al-Khayat et al., 1995; Craig and
Lehman, 2001; Lehman et al., 1994; McKillop and Geeves,
1993; Smith and Geeves, 2003; Smith et al., 2003; Vibert
et al., 1997). Under relaxing conditions, Tm lies at the
periphery of the actin ﬁlaments in the blocked position
whereas myosin heads are largely detached. With the rise
in calcium ions, Tm shifts to the closed state, where weak
interactions are allowed between myosin heads and thin
ﬁlament, and then to the open state where strong interactions
occur and generate force. The calcium-dependent transition
between the closed and open states of Tm is thought to be the
most important step for activation, with the strongly bound
myosin heads in the open state contributing to the high
cooperativity of activation (reviewed in Gordon et al., 2001;
Hitchcock-DeGregori, 2002). A blocked and/or closed Tm
position, where myosin heads are unable to strongly attach to
thin ﬁlaments and generate force, would be consistent with
the proportional inhibition of tension and stiffness inhibition
by W7 (Fig. 3, inset).
It is thought that the level of force during Ca21 activation
reﬂects the availability of open Tm states (Gordon et al.,
2000). The observation that W7 and BDM either interfere
each other at high pCa (level of force is higher than predicted
sum) or enhance each other at low pCa (level of force is
lower than the predicted sum) suggests a complex, calcium-
dependent redistribution of Tm states when both pathways
are inhibited. Our data thus support and extend the notion
that calcium activation of striated muscle contractility
involves an interplay between the activation of regulatory
complexes of the thin ﬁlament and the binding and cycling of
myosin heads to thin ﬁlaments, as previously proposed by
others (Fitzsimons et al., 2001; Fuchs, 1977; Gordon et al.,
1988; Guth and Potter, 1987; Hoar et al., 1987; Li and Fajer,
1994, 1998; Millar and Homsher, 1990; Swartz and Moss,
1992; Wakabayashi et al., 1991). W7 inhibition provides
a glimpse of the additional complexity of the calcium
regulation pathways and it can be exploited, either alone
or in combination with other effectors, to achieve a more
quantitative understanding of the elementary steps of
calcium activation pathways, especially the interdependence
of the various steps (see e.g., Razumova et al., 2000).
Tension cost and calcium activation of skeletal
and cardiac muscles
The tension cost as a function of calcium activation can be
examined in terms of a simple two-state model of force
generation based on the original 1957 Huxley model
(Huxley, 1957), where myosin heads switch between the
nonforce generating (weak) and force generating (strong)
states and hydrolyze one molecule of ATP per cycle
(reviewed in Sieck and Regnier, 2001). The transition
between the two groups of states can be described by fapp, the
forward rate constant, and gapp, the reverse rate constant
(Brenner, 1988; Kerrick et al., 1991; Kushmerick and
Krasner, 1982). In this model the ratio of ATPase/tension
equals the product of the number of half sarcomeres in the
ﬁber, the mean force generated by each myosin head (F) and
gapp. Since the number of half sarcomeres is constant for the
same sample, the changes of this ratio reﬂect changes of F,
gapp, or both.
The declining ATPase/tension ratio with increasing
activation level implies a decrease in either the mean force
of myosin head and/or in the rate of myosin head
dissociation. Conversely, the higher ratio during inhibition
over the entire pCa range (Fig. 8) implies increased myosin
mean force and/or higher myosin head dissociation rate (i.e.,
more myosin heads in the weak-binding states). It should be
noted that the experimental error in the ATPase/tension ratio
is substantial for the region near the onset of activation.
However, this error quickly declines as tension increases and
approaches the maximum. For this reason, comparison of
tension cost-pCa curves are more useful at pCa below the
midpoint of the activation, which is;5.6 for skeletal muscle
and ;5.4 for cardiac ﬁbers (see Fig. 8). The presence of the
leading component of ATPase curves between pCa 6.6 and
5.8 (brackets in Fig. 4) contributed at least partly to the high
tension cost near pCa 5.8–5.6. Interestingly, this leading
component is absent in the cardiac muscle and the tension
cost curve is independent of pCa. These data raise the
possibility that this inhibitor-sensitive component of ATPase
of skeletal muscle reﬂects the existence of a heretofore-
uncharacterized calcium sensitive actomyosin interaction
between pCa 6.6 and 5.8.
The tension cost-pCa curves reveal that the mouse cardiac
tissue is more efﬁciently coupled for tension generation over
the entire range of activation, whereas skeletal muscle
appears to be at maximum efﬁciency only at or near maximal
activation. It may be no coincidence that energy efﬁciency is
somehow optimized to coincide with the range of their
physiological levels of activation, which is submaximal for
cardiac ﬁbers and maximal for skeletal ﬁbers (Fabiato,
1981). The interplay of the two activation pathways may
play a role in the mechanism of optimization of energy-
tension coupling.
In summary, we have presented a novel use of W7 to
reversibly inhibit striated muscle activation. This inhibition
appears to act primarily via the binding to TnC and the
subsequent inactivation of the thin ﬁlaments. Examination of
the tension and ATPase curves over the entire range of
calcium activation in the presence of W7, BDM, and
a combination of both, have revealed the complexity and
interplay of thin ﬁlament- and thick ﬁlament-based activa-
tion pathways.
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